Showing results (451-460 of 517) with videos related to

Sort By:
Pageof 52
Molecular Therapy. Methods & Clinical Development|July 1, 2024
Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapyStuart Ellison, Karen Buckland, Yuko Learmonth, et al.
Neuro-Oncology|April 1, 2020
Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastomaJessica T Taylor, Stuart Ellison, Alina Pandele, et al.
American Journal of Therapeutics|May 11, 2004
Regulatory toxicology perspectives on the development of botanical drug products in the United StatesKuei-Meng Wu, James Farrelly, Debra Birnkrant, et al.
Wellcome Open Research|November 10, 2025
Collagen fibril formation at the plasma membrane occurs independently from collagen secretionAdam Pickard, Richa Garva, Antony Adamson, et al.
Plos One|December 15, 2010
Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic diseaseMarcelina Malinowska, Fiona L Wilkinson, Kia J Langford-Smith, et al.
Controlled Clinical Trials|February 1, 1996
Clinical trial enrollers vs. nonenrollers: the Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) projectL Gorkin, E B Schron, K Handshaw, et al.
Neuropathology and Applied Neurobiology|April 22, 2018
A nonmyeloablative chimeric mouse model accurately defines microglia and macrophage contribution in gliomaK Yu, A S Youshani, F L Wilkinson, et al.
American Journal of Hypertension|October 18, 2015
Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure TrialLin Y Chen, J Thomas Bigger, Kathleen T Hickey, et al.
The Journal of Experimental Medicine|July 13, 2017
Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASILArturo I Machuca-Parra, Alexander A Bigger-Allen, Angie V Sanchez, et al.
Diabetes Care|February 25, 2011
Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trialRoger T Anderson, K M Venkat Narayan, Patricia Feeney, et al.
Pageof 52